Predicting steroid responsiveness in patients with asthma using exhaled breath profiling

Exhaled breath contains disease‐dependent volatile organic compounds (VOCs), which may serve as biomarkers distinguishing clinical phenotypes in asthma. Their measurement may be particularly beneficial in relation to treatment response.

[1]  Arnaldo D'Amico,et al.  Electronic noses calibration procedure in the context of a multicentre medical study , 2012 .

[2]  P. J. Barnes,et al.  Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.

[3]  H. Haick,et al.  Diagnosis of head-and-neck cancer from exhaled breath , 2011, British Journal of Cancer.

[4]  P. Bradding,et al.  Subclinical phenotypes of asthma , 2010, Current opinion in allergy and clinical immunology.

[5]  R. Gerth van Wijk,et al.  Biomarkers in asthma and allergic rhinitis. , 2010, Pulmonary pharmacology & therapeutics.

[6]  I. Pavord,et al.  Non-eosinophilic cor ticosteroid unresponsive asthma , 1999, The Lancet.

[7]  Silvia Conforto,et al.  Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD , 2013, Journal of breath research.

[8]  Niki Fens,et al.  Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. , 2009, American journal of respiratory and critical care medicine.

[9]  H. Boushey,et al.  Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. , 1993, The American review of respiratory disease.

[10]  I. Adcock,et al.  Glucocorticoid resistance in inflammatory diseases , 2009, The Lancet.

[11]  P. Sterk,et al.  An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls. , 2012, Lung cancer.

[12]  Onofrio Resta,et al.  An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. , 2009, Lung cancer.

[13]  S. Anderson,et al.  Airway responsiveness : standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults , 1993 .

[14]  T. J. Vink,et al.  Effect of transportation and storage using sorbent tubes of exhaled breath samples on diagnostic accuracy of electronic nose analysis , 2012, Journal of breath research.

[15]  J. Cowan,et al.  Effects of steroid therapy on inflammatory cell subtypes in asthma , 2009, Thorax.

[16]  R. Hancox,et al.  The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. , 2001, American journal of respiratory and critical care medicine.

[17]  Ashley Woodcock,et al.  Non-invasive phenotyping using exhaled volatile organic compounds in asthma , 2011, Thorax.

[18]  Peter J Sterk,et al.  An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.

[19]  Bogusław Buszewski,et al.  Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.

[20]  S. Wenzel.  Asthma: defining of the persistent adult phenotypes , 2006, The Lancet.

[21]  Giorgio Pennazza,et al.  Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. , 2010, Chest.

[22]  R. Axel,et al.  A novel multigene family may encode odorant receptors: A molecular basis for odor recognition , 1991, Cell.

[23]  ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. , 2005, American journal of respiratory and critical care medicine.

[24]  A. Miller,et al.  Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.

[25]  F H Krouwels,et al.  Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD , 2011, European Respiratory Journal.

[26]  J. Cowan,et al.  Exhaled nitric oxide: a predictor of steroid response. , 2005, American journal of respiratory and critical care medicine.

[27]  N. Bârsan,et al.  Electronic nose: current status and future trends. , 2008, Chemical reviews.

[28]  H. Brown.  Treatment of chronic asthma with prednisolone; significance of eosinophils in the sputum. , 1958, Lancet.

[29]  D. Taylor,et al.  Using biomarkers in the assessment of airways disease. , 2011, The Journal of allergy and clinical immunology.

[30]  Zulfiqur Ali,et al.  Data analysis for electronic nose systems , 2006 .

[31]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[32]  Paolo Montuschi,et al.  The Electronic Nose in Respiratory Medicine , 2012, Respiration.

[33]  I. Pavord,et al.  Inflammometry to assess airway diseases , 2008, The Lancet.

[34]  M P van der Schee,et al.  External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.